Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

Kevin Arias is awarded at the X UAB Doctoral Workshop for the invention of a simpler malaria detection device

The new device, much simpler and more immediate than current techniques, would generate results in 20 minutes and detect malaria in the most remote regions of the planet.

News

Vall d'Hebron demonstrates that the gut microbiota can facilitate the diagnosis of Crohn's disease and ulcerative colitis

The quantification of the gut microbiota, combined with clinical data, would be useful to facilitate the correct diagnosis of patients and offer them the appropriate treatment for their pathology and also to prevent the appearance of flares.

News

Vall d'Hebron demonstrates that the gut microbiota can facilitate the diagnosis of Crohn's disease and ulcerative colitis

The quantification of the gut microbiota, combined with clinical data, would be useful to facilitate the correct diagnosis of patients and offer them the appropriate treatment for their pathology and also to prevent the appearance of flares.

News

Researcher Alba Torija, awarded for the best oral communication for the analysis of the cells involved in the rejection of solid organs

The advances, led by the VHIR Nephrology group, have been presented at the XVI Congress of the Catalan Transplantation Society.

News

Vall d'Hebron and IDIAP Jordi Gol collaborate in pediatric research in primary care

The joint work has received a runner-up prize for the best Oral Communication from the Catalan Pediatric Society.

News

Endolipid Therapeutics, the spin-off of Vall d’Hebron and GENESIS Ventures, emerges to develop a new strategy to reduce visceral and subcutaneous fat

Endolipid Therapeutics has developed a new approach to reducing visceral fat with therapeutic applications to treat, for example, fatty liver, and applications will be developed to reduce subcutaneous fat.

News

Vall d'Hebron participa un any més a la Festa de la Ciència

La Festa de la Ciència tancarà aquest diumenge la Biennal Ciutat i Ciència 2021 amb un ventall d'activitats per apropar la ciència a la ciutadania. Professionals de Vall d'Hebron reflexionaran sobre telemedicina, intel.ligència artificial i càncer, i mutacions.

News

Five VHIR research projects on COVID-19 are promoted by La Marató 2020

Vall d'Hebron is the center with the most promoted projects from La Marató 2020 to research on COVID-19. Five out of the six projects are coordinated by VHIR researchers.

News

Vall d’Hebron assumes the rotating presidency of the European University Hospital Alliance (EUHA)

Dr. Albert Salazar, manager of Vall d'Hebron University Hospital, assumes for the next six months the presidency of the European University Hospital Alliance (EUHA), an alliance formed by the largest university hospitals in Europe working in collaboration to improve the outcomes of patients from tod

News

The solidarity race "Km Contra El Cáncer Infantil" raises €15,000 for research on childhood cancer in Vall d’Hebron

The proceeds will go to the study of liquid biopsy for the early detection of relapses in osteosarcoma, a project of the Translational Research Group in Child and Adolescent Cancer at VHIR.

News

A work led by Vall d'Hebron demonstrates the relationship between immune-mediated inflammatory diseases and changes in diet

The study, carried out with more than 11,000 patients, aims to understand the effect of food on these diseases to give recommendations based on evidence.

News

Vall d'Hebron participates in the definition of microRNA profile as a biomarker to predict progression of COVID-19 in severe patients

Thanks to this finding, we may be able to predict severity in patients affected by SARS-CoV-2 and prevent its progression.

News

Vall d’Hebron collaborates in the development of a novel nano-encapsulation approach for efficient dopamine delivery in Parkinson’s treatment

In a study just published in the American Chemical Society's Journal "ACS Nano", polymeric nanoparticles inspired by natural neuromelanin were used to encapsulate dopamine and to be administered via intranasal to reach the brain for Parkinson's disease treatment. The effectiveness of this technique

News

Vall d’Hebron begins the clinical trial in pregnant women of the Pfizer-BioNTech vaccine against COVID-19

The clinical trial of the Pfizer-BioNTech vaccine in healthy pregnant women has begun today and the recruitment of volunteers to participate is underway.

News

Fast and cheap ‘super tests’ to detect malaria

Researchers have enhanced the ELISA test with high performance features to be able to detect malaria in a quantifiable way in one hour and with a sensitivity close to PCR.

News

SensePor association donates €8,780 for predoctoral grants in Vall d’Hebron

The association has raised euros7,800 for the Amics de Vall d'Hebron Predoctoral Grants Program and euros980 for the 'Solidarity Kerchief' campaign that promotes women's cancer research.

News

Vall d'Hebron integra la mirada de gènere en salut

L'Hospital Universitari Vall d'Hebron ha celebrat avui la 1a Jornada de Perspectiva de Gènere en Salut per reivindicar una Medicina adaptada a les necessitats especifiques de la dona. Introduir una mirada de gènere en la salut serà una de les línees estratègiques a desplegar en els propers quatre an

News

Dr. Magda Campins wins #Admirables 2021 award from Diario Médico and Correo Farmacéutico

The awards are an initiative to recognize the commitment and effort of healthcare professionals in a year marked by the COVID-19 pandemic.

News

Clinical and bioengineering researchers accelerate together towards the medicine of the future

The Vall d'Hebron Research Institute (VHIR) and the Institute for Bioengineering of Catalonia (IBEC) intensify their collaboration to face health challenges.

News

Vall d’Hebron has reached a record number of clinical trials despite the pandemic

2020 ended with the highest number of clinical trials recorded at the Vall d'Hebron Campus: 1,365 active and 319 new.